Hospitals for women are increasingly the target of attacks on the internet, but the women’s hospitalization rates are a relatively new phenomenon.
The new data comes from the Women’s Health Initiative at the University of Massachusetts Amherst, which recently published data on the number of women who have been hospitalized for cervical cancer in the United States, including information on whether they are vaccinated and what they were diagnosed with.
According to the data, the total number of cervical cancer cases in the US rose from 9.4 million in 2016 to 12.9 million in 2021, according to the CDC.
The overall increase in cases in 2021 was higher than any other year since 1979, and the increase was more than three times the rate seen between 2004 and 2011.
“The women’s health initiative has been tracking women’s cervical cancer for more than a decade, and we have been consistently surprised by the large increase in cervical cancer reported from 2017 to 2021,” said Dr. Nancy Hensley, the institute’s director.
“We have seen this increase over the past few years, which we attribute to improved detection and better treatments for women.”
The increase in the number and severity of cervical cancers was most notable among those women with advanced cancers in the first six months of the year.
More than 1,800 women were diagnosed during the six-month period, up from about 600 the previous year.
Women in their 50s accounted for almost 90 percent of cervical cases.
The data also shows that about 3,300 women received cancer screenings and treatment, compared to about 1,000 in 2020.
A lot of the women in the study had no previous history of cervical infection, which means they didn’t have symptoms or signs of cervical or pelvic cancer, according.
But they also had symptoms that might have led to an infection or a suspicion of cervical disease.
Overall, the numbers are consistent with the number reported by other studies.
For example, the American Cancer Society reported in February that there were nearly 1,200 new cases of cervical dysplasia each day in the U.S. in 2016, up 24 percent from a year earlier.
In contrast, the US Centers for Disease Control and Prevention reported that in 2017, there were 678 new cervical cancer deaths, down 6 percent from 2016.
More data on women’s hospitals is also coming soon.
In the next few months, Hensling hopes to share more information on how to use the Women on Web service and data from the National Women’s Hospital Survey to develop a tool for healthcare professionals to track cervical cancer data and trends in their offices.
“There’s been a lot of progress in identifying trends, but we still need to do more to understand and improve these patterns,” Hensing said.
The Women on Work website lists the number, type, and number of employees who have worked at a women’s cancer center.
The site has a section that describes how to report on the cancer status of a woman at work, and can also provide data on cervical cancer screenings, referrals, and other clinical and demographic data.
“I am grateful to the Women On Work project and their team for putting their expertise in data analysis to work to provide women with accurate information,” Haysley said.